EDELMAN JOSEPH
SEC CIK 1164426 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Dir, 10% | 11.83M | $20.15M | — | 2 | 2022-12-02 | 2025-02-19 |
| MGTX | MeiraGTx Holdings plc | Dir, 10% | 12.53M | $5.00M | — | 1 | 2024-08-12 | 2024-08-12 |
| ALDX | Aldeyra Therapeutics, Inc. | 10% | 9.28M | $2.12M | — | 3 | 2022-08-04 | 2024-04-04 |
| VRCA | Verrica Pharmaceuticals Inc. | 10% | 6.98M | $2.31M | — | 1 | 2023-12-27 | 2023-12-27 |
| LONA | LeonaBio, Inc. | Dir, 10% | 5.24M | $5.56M | — | 2 | 2022-06-29 | 2023-12-27 |
| ADMA | ADMA BIOLOGICS, INC. | 10% | 13.48M | — | $1.29M | 2 | 2021-09-23 | 2021-09-28 |
| YARW | Yarrow Bioscience, Inc. | 10% | 4.94M | — | $435.0K | 1 | 2021-08-16 | 2021-08-16 |
Most active insiders at SLDB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cumbo Alexander | Pres, CEO, Dir | — | $984.0K |
| 2 | Howton David T | COO | — | $433.6K |
| 3 | Tan Kevin | CFO, Treas | — | $329.5K |
| 4 | Hanrahan Jessie | Chief Regulatory Off | — | $297.4K |
| 5 | Brooks Gabriel | Chief Medical Off | — | $281.0K |
| 6 | Herzich Paul | CTO | — | $274.1K |
| 7 | Ganot Ilan | Dir | — | $82.4K |
| 8 | SMITH IAN F | Dir | — | — |
EDELMAN JOSEPH made no open-market trades at SLDB in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-21 | 2025-02-19 | SLDB | Solid Biosciences Inc. | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $4.03 | +5.00M | 11.83M | +73% | +$20.15M |
| I | 2024-08-14 | 2024-08-12 | MGTX | MeiraGTx Holdings plc | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $4.00 | +1.25M | 12.53M | +11% | +$5.00M |
| MI | 2024-04-08 | 2024-04-04+ | ALDX | Aldeyra Therapeutics, Inc. | EDELMAN JOSEPH | 10% | P - Purchase | $4.68 | +178.0K | 9.28M | +2% | +$833.9K |
| MI | 2023-12-29 | 2023-12-27+ | VRCA | Verrica Pharmaceuticals Inc. | EDELMAN JOSEPH | 10% | P - Purchase | $7.17 | +321.6K | 6.98M | +5% | +$2.31M |
| MI | 2023-12-29 | 2023-12-27+ | LONA | LeonaBio, Inc. | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $2.42 | +605.7K | 5.24M | +13% | +$1.46M |
| MI | 2022-12-06 | 2022-12-02 | SLDB | Solid Biosciences Inc. | EDELMAN JOSEPH | Dir, 10% | A - Grant | $7.05 | +2.60M | 73.1K | New | +$18.34M |
| I | 2022-08-10 | 2022-08-08 | ALDX | Aldeyra Therapeutics, Inc. | EDELMAN JOSEPH | 10% | P - Purchase | $7.24 | +97.0K | 11.24M | +0.9% | +$702.3K |
| I | 2022-08-08 | 2022-08-04 | ALDX | Aldeyra Therapeutics, Inc. | EDELMAN JOSEPH | 10% | P - Purchase | $6.17 | +95.1K | 11.00M | +0.9% | +$586.8K |
| MI | 2022-07-01 | 2022-06-29+ | LONA | LeonaBio, Inc. | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $2.99 | +1.37M | 4.80M | +40% | +$4.10M |
| MI | 2021-09-30 | 2021-09-28+ | ADMA | ADMA BIOLOGICS, INC. | EDELMAN JOSEPH | 10% | S - Sale | $1.15 | -260.6K | 13.48M | -2% | -$299.2K |
| I | 2021-09-28 | 2021-09-23 | ADMA | ADMA BIOLOGICS, INC. | EDELMAN JOSEPH | 10% | S - Sale | $1.27 | -780.0K | 14.02M | -5% | -$990.6K |
| I | 2021-08-18 | 2021-08-16 | YARW | Yarrow Bioscience, Inc. | EDELMAN JOSEPH | 10% | S - Sale | $1.74 | -250.0K | 4.94M | -5% | -$435.0K |
Purchase Sale Sale after option exercise All abbreviations